-
Product Insights
New1 Phosphatidylinositol 3 Phosphate 5 Kinase – Drugs In Development, 2024
The 1 Phosphatidylinositol 3 Phosphate 5 Kinase pipeline drugs market research report outlays comprehensive information on the 1 Phosphatidylinositol 3 Phosphate 5 Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Musculoskeletal Disorders, and Immunology which include indications of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia (FTD), Coronavirus Disease 2019 (COVID-19), Unspecified Viral Infections,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Censavudine in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Censavudine in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Censavudine in Progressive Supranuclear Palsy Drug Details: Censavudine (Festinavir, BMS-986001,OBP-601)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Censavudine in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Censavudine in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Censavudine in Amyotrophic Lateral Sclerosis Drug Details: Censavudine (Festinavir, BMS-986001,OBP-601)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Parkinson's Disease Drug Details: Buntanetap (ANVS-401 (Posiphen))...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hydromethylthionine Mesylate in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hydromethylthionine Mesylate in Mild Cognitive Impairment report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hydromethylthionine Mesylate in Mild Cognitive Impairment Drug Details: Hydromethylthionine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Alzheimer's Disease Drug Details: Buntanetap (ANVS-401 (Posiphen))...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Tipiracil Hydrochloride + Trifluridine) in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Tipiracil Hydrochloride + Trifluridine) in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Tipiracil Hydrochloride + Trifluridine) in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Tipiracil Hydrochloride + Trifluridine) in Squamous Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Tipiracil Hydrochloride + Trifluridine) in Squamous Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Tipiracil Hydrochloride + Trifluridine) in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Tipiracil Hydrochloride + Trifluridine) in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Tipiracil Hydrochloride + Trifluridine) in Rectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Tipiracil Hydrochloride + Trifluridine) in Rectal Cancer Drug...